ZIMMER BIOMET HOLDINGS INC (ZBH) Stock Analyst Ratings
USA • New York Stock Exchange • NYSE:ZBH • US98956P1021
86.67 USD
+0.65 (+0.76%)
Last: Jan 30, 2026, 03:40 PM
ChartMill assigns a Buy % Consensus number of 68% to ZBH. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 104.24. This target is 20.27% above the current price.
- ZBH was analyzed by 33 analysts. The buy percentage consensus is at 68. So analysts seem to be have mildly positive about ZBH.
- In the previous month the buy percentage consensus was at a similar level.
- ZBH was analyzed by 33 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-28 | UBS | Maintains | Sell -> Sell |
| 2026-01-09 | Bernstein | Maintains | Market Perform -> Market Perform |
| 2026-01-08 | BTIG | Reiterate | Buy -> Buy |
| 2026-01-05 | Evercore ISI Group | Upgrade | In-Line -> Outperform |
| 2025-12-16 | Baird | Downgrade | Outperform -> Neutral |
| 2025-12-11 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-11-10 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-11-06 | UBS | Maintains | Sell -> Sell |
| 2025-11-06 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-11-06 | Barclays | Maintains | Underweight -> Underweight |
| 2025-11-06 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2025-11-05 | BTIG | Maintains | Buy -> Buy |
| 2025-11-05 | Barclays | Maintains | Underweight -> Underweight |
| 2025-10-22 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-10-13 | BTIG | Maintains | Buy -> Buy |
| 2025-10-07 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2025-09-19 | Stifel | Maintains | Buy -> Buy |
| 2025-09-18 | Rothschild & Co | Initiate | Buy |
| 2025-08-08 | UBS | Maintains | Sell -> Sell |
| 2025-08-08 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-08-08 | Raymond James | Maintains | Outperform -> Outperform |
| 2025-07-08 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2025-05-12 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-05-07 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-05-06 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-05-06 | Stifel | Maintains | Buy -> Buy |
| 2025-05-06 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-05-06 | Raymond James | Maintains | Outperform -> Outperform |
| 2025-05-06 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-05-06 | Baird | Maintains | Outperform -> Outperform |
ZIMMER BIOMET HOLDINGS INC / ZBH FAQ
What do analysts expect the price target to be for ZIMMER BIOMET HOLDINGS INC (ZBH)?
33 analysts have analysed ZBH and the average price target is 104.24 USD. This implies a price increase of 20.27% is expected in the next year compared to the current price of 86.67.
Can you provide the consensus rating for ZIMMER BIOMET HOLDINGS INC stock?
The consensus rating for ZIMMER BIOMET HOLDINGS INC (ZBH) is 67.8788 / 100 . This indicates that analysts generally have a neutral outlook on the stock.